PHARMACOVIGILANCE MONITORING AT DIFFERENT STAGES OF DRUG DEVELOPMENT: IN INDIA

Shrikant Godiyal*

ABSTRACT

Pharmacovigilance (PV) is an exclusive research-based activity that keeps a persistent observation on the drug and certain or uncommon Adverse Drug Reactions (ADRs) that were undiscovered throughout the clinical trial. The drugs are discovered to cure the human beings or living beings but still after the administration of drugs, sometime serious harmful effects are monitored which is known as Adverse Effects. The monitoring of Adverse Effect depend on determining about the harmful effect or adverse effect of an isolated drug and also to prevent its further existence. AIM: The aim of this review article is to aware the Patients and the Healthcare Professionals about the crucial steps taken by the Indian Pharmacopoeia Commission in collaboration with World Health Organization (WHO) to frame the structure of Pharmacovigilance Programme of India (PvPI) which is actively participating in Collection and Reporting of various ADRs, ICSR, AE by Patients, Doctors and the Industries which are playing a key role in development and marketing of Drugs in the global market.

Keywords: Pharmacovigilance (Pv), Central Drug Standard Control Organization (CDSCO), National Coordination Committee (NCC), Adverse Drug Reactions (ADRs), Indian Pharmacopoeia Commission (IPC), World Health Organisation (WHO), Pharmacovigilance Programme of India